Skip to main content
Yating Wang, MD, Oncology, Southfield, MI

YatingWangMD

[Pronunciation: She/Her/Hers]

Oncology Southfield, MI

Hematologic Oncology

Physician

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

  • Office

    16001 West Nine Mile Rd. Fisher Center
    Ste. 401
    Southfield, MI 48075
    Phone+1 248-552-0620
    Fax+1 773-564-7401

Summary

  • Dr. Yating Wang is an oncologist in Southfield, MI and is affiliated with Ascension of Providence Hospital, Southfield Campus. Dr. Wang received the medical degree from West China University of Medical Sciences and has been in practice 3 years. Dr. Wang also speaks multiple languages, including Chinese (Mandarin). Dr. Wang specializes in hematologic oncology.

Education & Training

  • Ascension Providence/MSUCHM
    Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 2022 - 2025
  • Louis A Weiss Memorial Hospital
    Louis A Weiss Memorial HospitalResidency, Internal Medicine, 2019 - 2022
  • West China University of Medical Sciences
    West China University of Medical SciencesClass of 2015

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2022 - 2025
  • WI State Medical License
    WI State Medical License 2024 - 2025
  • IL State Medical License
    IL State Medical License 2019 - 2022
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of...  
    Qian Yu a, Yating Wang b, Ethan Ungchusri a, Mikin Patel a, Divya Kumari a, Thuong Van Ha a, Anjana Pillai c, Chih-yi Liao d, Osman Ahmed a, Journal of Interventional Medicine, 9/28/2023
  • The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options  
    Yating Wang 1 , Shou-Ching Tang 2, Cancer Metastasis Rev. 2022 Dec;41(4):975-990. doi: 10.1007/s10555-022-10066-y. Epub 2022 Oct 14. PMID: 36229710; PMCID: PMC9560885., 10/14/2022
  • Heart Rate Variability and Prognosis in Hemodialysis Patients: A Meta-Analysis  
    JOUR AU - Yang, Letian AU - Zhao, Yuliang AU - Qiao, Baiyu AU - Wang, Yating AU - Zhang, Ling AU - Cui, Tianlei AU - Fu, Ping PY, Blood Purification ER, 6/1/2021
  • Join now to see all

Other

Press Mentions

  • Survival Trends Among Patients with Metastatic NSCLC Before and After the Approval of Immunotherapy in the US
    Survival Trends Among Patients with Metastatic NSCLC Before and After the Approval of Immunotherapy in the USSeptember 27th, 2024
  • Deaths from Advanced Lung Cancer Have Dropped Significantly Since Immunotherapy Became Standard-of-Care
    Deaths from Advanced Lung Cancer Have Dropped Significantly Since Immunotherapy Became Standard-of-CareAugust 12th, 2024
  • Advanced Lung Cancer Deaths Drop with Immunotherapy
    Advanced Lung Cancer Deaths Drop with ImmunotherapyAugust 7th, 2024
  • Join now to see all

Research History

  • Visiting scholarUniversity of Massachusetts Medical School, Worcester, MA Gene therapy for cancer, Research Scholar PI: Dr. Miguel Esteves, associate professor at the Gene Therapy Center of University of Massachusetts Medical School 09/2015 - 09/2016 • Killing assay of several tumor suppressors on glioblasto2015 - 2016
  • Exchange medical studentUniversity of West Ontario, London, Canada London Regional Cancer Program, University of Western Ontario, London, Canada Immunotherapy for cancer, Exchange medical student PI: Jim Koropatnick, director of LRCP, professor of Oncology Department at UWO 09/2015 - 09/2016 • Investigation of Indoleam2014 - 2015

Professional Memberships

Other Languages

  • Chinese (Mandarin)